Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.69
CI's Cash-to-Debt is ranked lower than
68% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.15 vs. CI: 0.69 )
Ranked among companies with meaningful Cash-to-Debt only.
CI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.28  Med: 0.68 Max: 2.11
Current: 0.69
0.28
2.11
Equity-to-Asset 0.23
CI's Equity-to-Asset is ranked lower than
78% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. CI: 0.23 )
Ranked among companies with meaningful Equity-to-Asset only.
CI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.04  Med: 0.09 Max: 0.24
Current: 0.23
0.04
0.24
Debt-to-Equity 0.36
CI's Debt-to-Equity is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.59 vs. CI: 0.36 )
Ranked among companies with meaningful Debt-to-Equity only.
CI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.12  Med: 0.31 Max: 0.67
Current: 0.36
0.12
0.67
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Net Margin % 5.82
CI's Net Margin % is ranked higher than
74% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.87 vs. CI: 5.82 )
Ranked among companies with meaningful Net Margin % only.
CI' s Net Margin % Range Over the Past 10 Years
Min: 1.53  Med: 5.55 Max: 7.07
Current: 5.82
1.53
7.07
ROE % 17.85
CI's ROE % is ranked higher than
50% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.89 vs. CI: 17.85 )
Ranked among companies with meaningful ROE % only.
CI' s ROE % Range Over the Past 10 Years
Min: 7  Med: 17.74 Max: 28.9
Current: 17.85
7
28.9
ROA % 4.09
CI's ROA % is ranked lower than
57% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.25 vs. CI: 4.09 )
Ranked among companies with meaningful ROA % only.
CI' s ROA % Range Over the Past 10 Years
Min: 0.72  Med: 3.1 Max: 3.81
Current: 4.09
0.72
3.81
3-Year Revenue Growth Rate 7.90
CI's 3-Year Revenue Growth Rate is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. CI: 7.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 9.1 Max: 31.6
Current: 7.9
0
31.6
3-Year EPS without NRI Growth Rate 3.90
CI's 3-Year EPS without NRI Growth Rate is ranked lower than
88% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.70 vs. CI: 3.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 6.6 Max: 79.9
Current: 3.9
0
79.9
GuruFocus has detected 1 Warning Sign with Cigna Corp CI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CI's 30-Y Financials

Financials (Next Earnings Date: 2018-11-02)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

CI Guru Trades in Q3 2017

George Soros 76,800 sh (New)
Joel Greenblatt 34,946 sh (+117.81%)
Pioneer Investments 18,887 sh (unchged)
Mairs and Power 4,559 sh (unchged)
David Dreman 39 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Barrow, Hanley, Mewhinney & Strauss 1,963,690 sh (-0.78%)
Dodge & Cox 13,008,253 sh (-6.48%)
Vanguard Health Care Fund 6,235,689 sh (-9.49%)
Alan Fournier 218,800 sh (-12.79%)
Larry Robbins 3,083,753 sh (-17.62%)
Richard Pzena 1,350,411 sh (-24.27%)
Mario Gabelli 4,050 sh (-33.06%)
NWQ Managers 264,719 sh (-33.13%)
Steven Cohen 69,700 sh (-50.88%)
Lee Ainslie 111,800 sh (-92.28%)
» More
Q4 2017

CI Guru Trades in Q4 2017

Caxton Associates 6,488 sh (New)
Paul Tudor Jones 3,634 sh (New)
Pioneer Investments 144,259 sh (+663.80%)
George Soros 121,800 sh (+58.59%)
Joel Greenblatt 36,285 sh (+3.83%)
Mario Gabelli 4,050 sh (unchged)
David Dreman 39 sh (unchged)
Mairs and Power 4,559 sh (unchged)
Lee Ainslie Sold Out
NWQ Managers Sold Out
Barrow, Hanley, Mewhinney & Strauss 1,942,695 sh (-1.07%)
Larry Robbins 2,619,078 sh (-15.07%)
Vanguard Health Care Fund 5,212,652 sh (-16.41%)
Dodge & Cox 10,734,593 sh (-17.48%)
Steven Cohen 55,100 sh (-20.95%)
Richard Pzena 1,008,999 sh (-25.28%)
Alan Fournier 133,187 sh (-39.13%)
» More
Q1 2018

CI Guru Trades in Q1 2018

Jim Simons 315,100 sh (New)
Jana Partners 300,678 sh (New)
Lee Ainslie 47,210 sh (New)
Leucadia National 30,000 sh (New)
Steven Cohen 175,700 sh (+218.87%)
George Soros 213,700 sh (+75.45%)
Joel Greenblatt 44,604 sh (+22.93%)
Paul Tudor Jones 4,358 sh (+19.92%)
Barrow, Hanley, Mewhinney & Strauss 2,044,137 sh (+5.22%)
Caxton Associates 6,671 sh (+2.82%)
Pioneer Investments 147,905 sh (+2.53%)
David Dreman 39 sh (unchged)
Mario Gabelli 4,050 sh (unchged)
George Soros 32,300 sh (unchged)
Alan Fournier Sold Out
Mairs and Power Sold Out
Dodge & Cox 10,401,022 sh (-3.11%)
Vanguard Health Care Fund 5,049,352 sh (-3.13%)
Larry Robbins 2,150,778 sh (-17.88%)
Richard Pzena 191,526 sh (-81.02%)
» More
Q2 2018

CI Guru Trades in Q2 2018

Carl Icahn 503,380 sh (New)
Jim Simons 788,000 sh (+150.08%)
Paul Tudor Jones 9,443 sh (+116.68%)
Richard Pzena 368,856 sh (+92.59%)
Pioneer Investments 196,294 sh (+32.72%)
Joel Greenblatt 53,793 sh (+20.60%)
Dodge & Cox 10,407,762 sh (+0.06%)
Mario Gabelli 4,050 sh (unchged)
Leucadia National Sold Out
George Soros Sold Out
Jana Partners Sold Out
Barrow, Hanley, Mewhinney & Strauss 1,968,371 sh (-3.71%)
Lee Ainslie 43,890 sh (-7.03%)
Larry Robbins 1,670,007 sh (-22.35%)
Vanguard Health Care Fund 3,829,489 sh (-24.16%)
Steven Cohen 115,000 sh (-34.55%)
Caxton Associates 3,886 sh (-41.75%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Dodge & Cox 2018-06-30 Add 0.06%$164.65 - $180.95 $ 202.2317%10,407,762
Vanguard Health Care Fund 2018-06-30 Reduce -24.16%0.46%$164.65 - $180.95 $ 202.2317%3,829,489
Barrow, Hanley, Mewhinney & Strauss 2018-06-30 Reduce -3.71%0.02%$164.65 - $180.95 $ 202.2317%1,968,371
Carl Icahn 2018-06-30 New Buy0.35%$164.65 - $180.95 $ 202.2317%503,380
Richard Pzena 2018-06-30 Add 92.59%0.15%$164.65 - $180.95 $ 202.2317%368,856
Joel Greenblatt 2018-06-30 Add 20.60%0.02%$164.65 - $180.95 $ 202.2317%53,793
George Soros 2018-06-30 Sold Out 0.66%$164.65 - $180.95 $ 202.2317%0
Leucadia National 2018-06-30 Sold Out 0.36%$164.65 - $180.95 $ 202.2317%0
Dodge & Cox 2018-03-31 Reduce -3.11%0.05%$164 - $226.22 $ 202.234%10,401,022
Vanguard Health Care Fund 2018-03-31 Reduce -3.13%0.07%$164 - $226.22 $ 202.234%5,049,352
Barrow, Hanley, Mewhinney & Strauss 2018-03-31 Add 5.22%0.03%$164 - $226.22 $ 202.234%2,044,137
George Soros 2018-03-31 Add 75.45%0.28%$164 - $226.22 $ 202.234%213,700
Richard Pzena 2018-03-31 Reduce -81.02%0.82%$164 - $226.22 $ 202.234%191,526
Joel Greenblatt 2018-03-31 Add 22.93%0.02%$164 - $226.22 $ 202.234%44,604
Leucadia National 2018-03-31 New Buy0.36%$164 - $226.22 $ 202.234%30,000
Dodge & Cox 2017-12-31 Reduce -17.48%0.34%$184.99 - $209.97 $ 202.232%10,734,593
Vanguard Health Care Fund 2017-12-31 Reduce -16.41%0.41%$184.99 - $209.97 $ 202.232%5,212,652
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -1.07%0.01%$184.99 - $209.97 $ 202.232%1,942,695
Richard Pzena 2017-12-31 Reduce -25.28%0.34%$184.99 - $209.97 $ 202.232%1,008,999
George Soros 2017-12-31 Add 58.59%0.25%$184.99 - $209.97 $ 202.232%121,800
Joel Greenblatt 2017-12-31 Add 3.83%$184.99 - $209.97 $ 202.232%36,285
NWQ Managers 2017-12-31 Sold Out 0.72%$184.99 - $209.97 $ 202.232%0
Dodge & Cox 2017-09-30 Reduce -6.48%0.13%$167.5 - $187.62 $ 202.2314%13,008,253
Vanguard Health Care Fund 2017-09-30 Reduce -9.49%0.24%$167.5 - $187.62 $ 202.2314%6,235,689
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Reduce -0.78%$167.5 - $187.62 $ 202.2314%1,963,690
Richard Pzena 2017-09-30 Reduce -24.27%0.4%$167.5 - $187.62 $ 202.2314%1,350,411
NWQ Managers 2017-09-30 Reduce -33.13%0.3%$167.5 - $187.62 $ 202.2314%264,719
George Soros 2017-09-30 New Buy0.43%$167.5 - $187.62 $ 202.2314%76,800
Joel Greenblatt 2017-09-30 Add 117.81%0.05%$167.5 - $187.62 $ 202.2314%34,946
Mario Gabelli 2017-09-30 Reduce -33.06%$167.5 - $187.62 $ 202.2314%4,050
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NAS:ESRX, NYSE:HUM, NYSE:AET, NYSE:ANTM, NYSE:CNC, NYSE:CVS, NYSE:WCG, NYSE:MOH, BSP:ODPV3, BSP:QUAL3, NAS:MGLN, XPAR:GDS, NAS:HIIQ, OSTO:MCOV B, ROCO:6665, ATH:IATR, ASX:ONT, TSXV:NAC, MIL:HI, OTCPK:HFRN » details
Traded in other countries:CGN.Germany,
Headquarter Location:USA
Cigna Corp operates in the healthcare industry. It provides medical, dental, disability, life and accident insurance products.

Cigna is one of the largest managed-care organizations in the United States, with a little over 14 million medical members. The firm provides health insurance services to individuals mainly through the group (employer) market. Cigna is one of the leaders in the commercial self-funded fee market, which is where a good portion of the growth has and will continue to emanate from for the large-group cohort. The firm also participates in other insurance and retirement businesses that make up a material portion of its total operations.

Guru Investment Theses on Cigna Corp

Jeff Auxier Comments on Cigna - May 07, 2018

On March 8, 2018, Cigna (NYSE:CI) entered into a definitive agreement to acquire Express Scripts Holding Company for $67B, or $92 per share. This buyout would broaden the portfolio of Cigna’s specialty services and boost their focus on advanced analytics. Combining the companies’ strengths will allow them to use a patient’s medical history to improve treatments and lower costs while simplifying the healthcare supply chain. The merger consideration will consist of $48.75 in cash and 0.2434 shares of stock of the combined company per ESRX share. Upon closing the transaction, Cigna shareholders will own approximately 64% of the company and Express Scripts shareholders will own 36%. Current CEO of Cigna, David Cordani, will lead the combined company with Tim Wentworth, current CEO of Express Scripts, transitioning to President of Express Scripts, Inc. The deal is being closely watched and scrutinized by the Department of Justice who recently asked both companies for additional information. The Justice Department successfully blocked both Aetna from buying Humana Inc. and Anthem Inc. from acquiring Cigna in 2017, but Cigna is still confident in their ability to gain regulatory approval and complete the acquisition by the end of 2018.



From Jeff Auxier (Trades, Portfolio)'s first-quarter 2018 shareholder letter.

Check out Jeff Auxier latest stock trades

Top Ranked Articles about Cigna Corp

Department of Justice Approves Cigna-Express Scripts Deal The companies expect the deal to close by year-end
Clearing a major hurdle in the health care space’s path to consolidation, Cigna Corp. (NYSE:CI) announced on Monday its $52 billion acquisition of Express Scripts Holding Co. (NASDAQ:ESRX) was approved by the U.S. Department of Justice, sending shares higher in after-hours trading. Read more...
Crain's Custom Media And Cigna Announce Illinois' Healthiest Employers For 2018
Express Scripts Reminds Stockholders to Vote "FOR" the Merger with Cigna
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement with Cigna
Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote "FOR" Merger with Cigna
UnitedHealth With Ex-Dividend on Sept. 6 Company has paid dividends of $3.15 over the past 12 months
UnitedHealth (NYSE:UNH) announced its most recent quarterly dividend on Aug. 8 with an ex-dividend date of Sept. 6. The company is one of four health care companies in the Dow Jones Industrial Average and the only Dow Jones company focused on health care plans. In the S&P 500 its closest competitors by market cap include Anthem, Aetna and Humana. Read more...
Long-term Cigna Shareholder Glenview Capital Submits Open Letter to Shareholders in Support of Cigna / Express Scripts Transaction
Cigna Dental Plans Added to PlanSource Advantage Program
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cigna Corporation - CI
Wall Street Edges Higher Wednesday United Continental raises outlook
The U.S. stock market advanced in morning trading Wednesday as Federal Reserve Chairman Jerome Powell appeared before Congress for the second day of testimony on monetary policy. Read more...

Ratios

vs
industry
vs
history
PE Ratio 19.60
CI's PE Ratio is ranked higher than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. CI: 19.60 )
Ranked among companies with meaningful PE Ratio only.
CI' s PE Ratio Range Over the Past 10 Years
Min: 3.25  Med: 13.51 Max: 25.82
Current: 19.6
3.25
25.82
Forward PE Ratio 13.48
CI's Forward PE Ratio is ranked higher than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.27 vs. CI: 13.48 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 19.60
CI's PE Ratio without NRI is ranked higher than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. CI: 19.60 )
Ranked among companies with meaningful PE Ratio without NRI only.
CI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 3.25  Med: 13.48 Max: 25.82
Current: 19.6
3.25
25.82
Price-to-Owner-Earnings 12.16
CI's Price-to-Owner-Earnings is ranked higher than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.47 vs. CI: 12.16 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 1.91  Med: 9.76 Max: 40.5
Current: 12.16
1.91
40.5
PB Ratio 3.34
CI's PB Ratio is ranked higher than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.42 vs. CI: 3.34 )
Ranked among companies with meaningful PB Ratio only.
CI' s PB Ratio Range Over the Past 10 Years
Min: 0.52  Med: 2.23 Max: 4.02
Current: 3.34
0.52
4.02
PS Ratio 1.16
CI's PS Ratio is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.73 vs. CI: 1.16 )
Ranked among companies with meaningful PS Ratio only.
CI' s PS Ratio Range Over the Past 10 Years
Min: 0.13  Med: 0.68 Max: 1.37
Current: 1.16
0.13
1.37
Price-to-Free-Cash-Flow 11.75
CI's Price-to-Free-Cash-Flow is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.78 vs. CI: 11.75 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.8  Med: 11.39 Max: 125.82
Current: 11.75
1.8
125.82
Price-to-Operating-Cash-Flow 10.53
CI's Price-to-Operating-Cash-Flow is ranked higher than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.15 vs. CI: 10.53 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.51  Med: 9.19 Max: 34.8
Current: 10.53
1.51
34.8
EV-to-Revenue 1.16
CI's EV-to-Revenue is ranked lower than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. CI: 1.16 )
Ranked among companies with meaningful EV-to-Revenue only.
CI' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.1  Med: 0.7 Max: 1.4
Current: 1.16
-0.1
1.4
Shiller PE Ratio 29.57
CI's Shiller PE Ratio is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.53 vs. CI: 29.57 )
Ranked among companies with meaningful Shiller PE Ratio only.
CI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 3.12  Med: 17.12 Max: 36.78
Current: 29.57
3.12
36.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.02
CI's Dividend Yield % is ranked lower than
100% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. CI: 0.02 )
Ranked among companies with meaningful Dividend Yield % only.
CI' s Dividend Yield % Range Over the Past 10 Years
Min: 0.02  Med: 0.06 Max: 0.57
Current: 0.02
0.02
0.57
Forward Dividend Yield % 0.02
CI's Forward Dividend Yield % is ranked lower than
100% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.33 vs. CI: 0.02 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.02
CI's 5-Year Yield-on-Cost % is ranked lower than
100% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.89 vs. CI: 0.02 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.02  Med: 0.06 Max: 0.57
Current: 0.02
0.02
0.57
3-Year Average Share Buyback Ratio 2.00
CI's 3-Year Average Share Buyback Ratio is ranked higher than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.50 vs. CI: 2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.8  Med: 2.8 Max: 11.7
Current: 2
-5.8
11.7

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 5.72
CI's Price-to-Tangible-Book is ranked higher than
74% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.76 vs. CI: 5.72 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.73  Med: 3.46 Max: 28
Current: 5.72
0.73
28
Price-to-Intrinsic-Value-Projected-FCF 1.25
CI's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.08 vs. CI: 1.25 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.28  Med: 0.8 Max: 1.6
Current: 1.25
0.28
1.6
Price-to-Median-PS-Value 1.70
CI's Price-to-Median-PS-Value is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. CI: 1.70 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.31  Med: 0.94 Max: 3.05
Current: 1.7
0.31
3.05
Price-to-Graham-Number 2.24
CI's Price-to-Graham-Number is ranked higher than
77% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.60 vs. CI: 2.24 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.5  Med: 1.47 Max: 3.75
Current: 2.24
0.5
3.75

More Statistics

Revenue (TTM) (Mil) $43,770.00
EPS (TTM) $ 10.32
Beta0.85
Volatility21.35%
52-Week Range $163.02 - 227.13
Shares Outstanding (Mil)243.36

Analyst Estimate

Dec18 Dec19 Dec20 Dec21
Revenue (Mil $) 44,378 82,088 53,299
EBIT (Mil $) 3,603 5,401 5,211
EBITDA (Mil $) 4,220 6,114 5,451 6,016
EPS ($) 12.77 14.35 16.55 18.59
EPS without NRI ($) 12.77 14.35 16.55 18.59
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.90%
Dividends per Share ($) 0.04 0.04 0.04

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}